NCT06997068 2026-04-03
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Mayo Clinic
Phase 2 Recruiting
Mayo Clinic
Emory University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center